Novo Nordisk announced headline results from STEP UP, a phase IIIb trial investigating subcutaneous semaglutide 7.2 mg for obesity Novo Nordisk announced headline results from STEP UP, a phase IIIb trial in the global STEP programme
This helps ensure safety and effectiveness in your weight loss journey
Duration depends on your goals, response, and a providers clinical recommendation
If you want a fully regulated, clinically tested medication, Ozempic is the gold standard especially if you have type 2 diabetes and insurance coverage
A reduction in the supply of these nutrients, on the other hand, may lead to follicle loss and damage
As always, you should speak with a licensed provider about whether compounded GLP-1 medications are right for you